ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Catalent Sets Chinese Ventures

by Jean-François Tremblay
March 18, 2013 | APPEARED IN VOLUME 91, ISSUE 11

Catalent, a New Jersey-based pharmaceutical services provider, is setting up two new ventures in China. In the first deal, Cata­lent has agreed to acquire a majority stake in Zhejiang Jiang Yuan Tang Biotechnology, a Zhejiang-based producer of soft gelatin capsules used for nutritional products. In the second deal, Catalent is setting up a joint venture with the Chinese contract research giant ShangPharma. The partners will establish a 31,000-sq-ft lab in Shanghai that will provide packaging and labeling, storage, and distribution services to drug companies conducting clinical trials.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment